Fitch Ratings said Thursday that it has affirmed Boston Scientific Corp.'s (BSX) Issuer Default Rating at 'BBB-'.
The rating action applies to about $4.26 billion of debt.
The Rating Outlook is Stable.
The key rating drivers for this credit are leverage, EBITDA margins, free cash flow and general operational stability, Fitch said.
For comments and feedback: editorial@rttnews.com